PGNX Market Cap History



Below is a table of the PGNX market cap history going back to 3/5/2010:

Date PGNX Market Cap
3/5/2010149.87M
5/5/2010201.20M
8/4/2010164.04M
11/3/2010165.19M
3/4/2011193.50M
5/4/2011251.90M
8/3/2011199.89M
11/2/2011211.02M
3/5/2012305.10M
5/1/2012352.84M
8/3/2012149.76M
11/5/2012101.41M
3/8/2013190.72M
5/7/2013223.55M
8/9/2013312.63M
11/6/2013231.74M
3/7/2014327.00M
5/2/2014250.40M
8/4/2014327.61M
11/3/2014326.22M
3/10/2015463.80M
5/1/2015364.94M
8/3/2015596.50M
11/3/2015569.61M
3/7/2016342.74M
5/2/2016381.21M
7/28/2016406.61M
11/3/2016344.65M
3/6/2017771.39M
5/1/2017580.76M
8/4/2017408.97M
10/30/2017429.35M
3/5/2018514.45M
5/4/2018502.02M
7/26/2018558.41M
11/5/2018449.77M
3/11/2019347.47M
4/25/2019414.26M
5/6/2019462.45M
8/5/2019411.37M
1/12/2015102.19M
11/4/2019506.43M
3/9/2020347.25M
5/4/2020336.86M

Also see: PGNX Shares Outstanding History
and PGNX YTD Return
PGNX Historical Market Cap:
+8.29% CAGR
PGNX Historical Market Cap: +8.29% CAGR

Mouse over chart for data details
3/5/2010 ...5/4/2020
Progenics Pharmaceuticals is an oncology company focused on the development and commercialization of medicines and artificial intelligence to find, fight and follow cancer. Co.'s product candidates include: AZEDRA® (iobenguane I 131), which is a radiotherapeutic for the treatment of adult and pediatric patients 12 years and older with iobenguane scan positive or metastatic pheochromocytoma or paraganglioma who require systemic anticancer therapy; and 1095, which is a prostate-specific membrane antigen-targeted iodine-131 labeled small molecule that is designed to deliver a dose of beta radiation directly to prostate cancer cells with minimal impact on the surrounding healthy tissues. We show 44 historical shares outstanding datapoints in our PGNX shares outstanding history coverage, used to compute PGNX market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing PGNX market cap history over the course of time is important for investors interested in comparing PGNX's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of PGNX versus a peer is one thing; comparing PGNX market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like PGNX can fluctuate over the course of history. With this page we aim to empower investors researching PGNX by allowing them to research the PGNX market cap history.
Quotes delayed 20 minutes

Email EnvelopeFree PGNX Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Progenics Pharmaceuticals (PGNX) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

PGNY Market Cap History
PHAS Market Cap History
PHAT Market Cap History
PHIO Market Cap History
PIII Market Cap History
PIRS Market Cap History
PKI Market Cap History
PLRX Market Cap History
PLSE Market Cap History
PLUR Market Cap History
More Healthcare companies »

 

PGNX Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2024, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 9.5%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 9.5%.